Related Experiment Videos
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH)
1Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris.
Advances in Experimental Medicine and Biology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.
Hematology (Amsterdam, Netherlands)·2016
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].
Annales francaises d'anesthesie et de reanimation·2013
[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays].
Journal des maladies vasculaires·2013
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.
Thrombosis and haemostasis·2011
[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Journal des maladies vasculaires·2011
The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.
Advances in experimental medicine and biology·2026
Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.
Advances in experimental medicine and biology·2026
Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.
Advances in experimental medicine and biology·2026
Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.
Advances in experimental medicine and biology·2026
Autonomous Oscillations of NF-κB.
Advances in experimental medicine and biology·2026
An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.
Advances in experimental medicine and biology·2026
A Novel Sequential Regimen of Efgartigimod and Telitacicept as Fast-Acting Treatment for Impeding Crisis of MuSK-MG.
Immunity, inflammation and disease·2026
Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders.
Expert review of medical devices·2026
Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.
The Yale journal of biology and medicine·2026